Diabetes and Cardiovascular Disease (3rd Ed., 3rd ed. 2023) Contemporary Cardiology Series
Coordonnateurs : Johnstone Michael, Veves Aristidis
This third edition of the book offers an up-to-date review of Diabetes Mellitus with a focus on both Micro- and Macrovascular Disease. The text includes a review of the basic concepts of : Diabetes and Vascular Disease, including Endothelial Dysfunction; The Effect of Insulin on the Vascular System; The Mechanism of Atherosclerosis in Diabetes Mellitus and the Role of Inflammation on the Vascular Tree; and The Role of the Renin-Angiotensin-Aldosteronism on Diabetes Mellitus. Chapters will discuss the Genetics of Type 2 Diabetes Mellitus as well as the Metabolic Syndrome. Other chapters discuss the Risk Factors of Diabetes and Vascular Disease, including Hypertension; Dyslipidemia; and Thrombosis. The book also reviews Microcirculation; Diabetic Nephropathy; Diabetic Retinopathy; as well as the Epidemiology, Diagnosis, and Treatment of Peripheral Vascular Disease; Diabetes and Coronary Artery Disease; Diabetes and Percutaneous Interventions; Diabetes and Cardiac Surgery; and Diabetes and Heart Failure. Chapters conclude with a review of the present-day Treatment of the Diabetic Patient.
Diabetes and Cardiovascular Disease, 3rd Edition, offers practicing physicians a cutting-edge scientific and clinical review of diabetic cardiovascular disease, providing both a deeper understanding of its pathology and all the day-to-day practical knowledge needed to treat patients effectively.
Dr. Michael T. Johnstone, MD, is the Director of Clinical Cardiology and Director of the Cardiology Fellowship Program at St. Elizabeth's Medical Center, and an Associate Professor of Medicine at Tufts University School of Medicine. Board certified in internal medicine, cardiovascular disease, vascular medicine, nuclear medicine, echocardiography, cardiac CT and vascular ultrasound, Dr. Johnstone specializes in coronary artery disease, diabetic heart disease, general cardiology, non-invasive cardiovascular imaging, and valvular heart disease. He earned his medical degree in 1982 from McGill University in Montreal, Canada and did his residency at Montreal General Hospital. He completed his Cardiology Fellowship at McGill University, the Montreal Heart Institute and the Brigham and Women’s Hospital. He spent 7 years as the Director of the Diabetes and Cardiovascular Program at the Joslin-Beth Israel Deaconess Medical Center. His research interests include non-invasive imaging, atherosclerosis, acute cardiovascular disease/ plaque disruption and diabetes mellitus.
Michael Johnstone, MD, CM, FRCP(C), FACC, FAHA, FVSM, FASE, FASNC,
Director, Cardiovascular Fellowship Program and Clinical Program
Dr. Aristidis Veves is the Director of the Rongxiang Xu, MD, Center for Regenerative Therapeutics and the Research Director of the Joslin-Beth Israel Deaconess Foot Center and of the Microcirculation Lab, and Rongxiang Xu, MD Professor of Surgery at Harvard Medical School. He received his M.D. from the Medical School, Aristotelion University of Thessaloniki (Greece) in 1981, his M.Sc. from the Faculty of Medicine, University of Manchester (U.K.) in 1991, and his D.Sc. from Athens Medical School (Greece) in 1993. Dr. Veves did his internship and residency
Offers a comprehensive overview of the mechanisms of diabetic cardiovascular disease
Provides a review of the new guidelines of care and treatment for diabetic heart disease
Appeals to a broad audience of cardiologists, nephrologists, neurologists, vascular specialists, and ophthalmologists
Date de parution : 06-2023
Ouvrage de 1086 p.
15.5x23.5 cm
Thèmes de Diabetes and Cardiovascular Disease :
Mots-clés :
Diabetes and Cardiovascular Disease; Atherosclerosis in Diabetes Mellitus; Diabetes and Cardiac Surgery; Diabetes and Heart Failure; Diabetes; Diabetes mellitus; Cardiovascular Disease; Metabolic Syndrome; Endothelial Dysfunction; Oral Hypglycemic; Macrovascular Disease; Microvascular Disease; Genetics of Type 2 Diabetes Mellitus; Diabetic Nephropathy; Diabetic Retinopathy; Peripheral Vascular Disease; Percutaneous Interventions of Diabetic Patients; Hypertension; Insulin
